在临床实践中使用基因型时，表型转化的重要性。
The importance of phenoconversion when using the genotype in clinical practice.
机构信息
Department of Pharmacotherapy & Translational Research, University of Florida, College of Pharmacy, Gainesville, FL 32608, USA.
Center for Pharmacogenomics & Precision Medicine, University of Florida, College of Pharmacy, Gainesville, FL 32608, USA.
出版信息
Pharmacogenomics. 2022 Sep;23(14):749-752. doi: 10.2217/pgs-2022-0087. Epub 2022 Sep 14.
Abstract
Tweetable abstract Clinical phenoconversion needs to be incorporated when interpreting and applying results in clinical care. This article describes how this can be performed either manually or by utilizing online tools and resources. #Phenoconversion #Pharmacogenomics.
摘要
可推文的摘要
在临床护理中解释和应用结果时，需要纳入临床表型转化。本文描述了如何手动执行此操作，或利用在线工具和资源来执行此操作。#表型转化#药物基因组学。
相似文献
1
The importance of phenoconversion when using the genotype in clinical practice.在临床实践中使用基因型时，表型转化的重要性。
Pharmacogenomics. 2022 Sep;23(14):749-752. doi: 10.2217/pgs-2022-0087. Epub 2022 Sep 14.
2
CYP2D6 pharmacogenetics and phenoconversion in personalized medicine.CYP2D6 药物遗传学和个体化医学中的表型转化。
Expert Opin Drug Metab Toxicol. 2022 Nov;18(11):769-785. doi: 10.1080/17425255.2022.2160317. Epub 2023 Jan 3.
3
How to Integrate CYP2D6 Phenoconversion Into Clinical Pharmacogenetics: A Tutorial.如何将 CYP2D6 表型转化纳入临床药物遗传学：教程。
Clin Pharmacol Ther. 2021 Sep;110(3):677-687. doi: 10.1002/cpt.2354. Epub 2021 Jul 28.
4
Addressing phenoconversion: the Achilles' heel of personalized medicine.应对表型转换：个性化医疗的致命弱点。
Br J Clin Pharmacol. 2015 Feb;79(2):222-40. doi: 10.1111/bcp.12441.
5
Pitfalls and challenges associated with phenoconversion in forensic toxcicology.法毒物学中表型转化相关的陷阱和挑战。
Forensic Sci Int Genet. 2021 Mar;51:102433. doi: 10.1016/j.fsigen.2020.102433. Epub 2020 Nov 28.
6
Pharmacist-Led Medication Evaluation Considering Pharmacogenomics and Drug-Induced Phenoconversion in the Treatment of Multiple Comorbidities: A Case Report.药剂师主导的药物评估考虑了药物基因组学和药物诱导表型转化在治疗多种合并症中的应用：一例报告。
Medicina (Kaunas). 2021 Sep 10;57(9):955. doi: 10.3390/medicina57090955.
7
An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.对 5408 名澳大利亚患者 CYP2D6、CYP2C19、CYP2C9 和 VKORC1 基因进行基因分型后的等位基因、基因型和表型频率、可操作的药物基因组学 (PGx) 变异体和表型转化分析。
J Neural Transm (Vienna). 2019 Jan;126(1):5-18. doi: 10.1007/s00702-018-1922-0. Epub 2018 Sep 6.
8
Pharmacogenomics in psychiatry - the challenge of cytochrome P450 enzyme phenoconversion and solutions to assist precision dosing.精神医学中的药物基因组学——细胞色素 P450 酶表型转化的挑战及精准剂量给药的解决方案
Pharmacogenomics. 2022 Oct;23(15):857-867. doi: 10.2217/pgs-2022-0104. Epub 2022 Sep 28.
9
CYP2D6 and pharmacogenomics: where does future research need to focus? Part 2: clinical aspects.细胞色素P450 2D6与药物基因组学：未来研究需聚焦于何处？第二部分：临床方面。
Pharmacogenomics. 2014 Jun;15(8):1055-8. doi: 10.2217/pgs.14.27.
10
Keeping pace with haplotype discovery: innovative methods to assign function.紧跟单倍型发现的步伐：赋予功能的创新方法。
Pharmacogenomics. 2022 Mar;23(4):255-262. doi: 10.2217/pgs-2021-0149. Epub 2022 Jan 27.
引用本文的文献
1
Implementing a pragmatic clinical trial to tailor opioids for chronic pain on behalf of the IGNITE ADOPT PGx investigators.代表 IGNITE ADOPT PGx 研究者实施一项实用临床试验，以针对慢性疼痛调整阿片类药物。
Clin Transl Sci. 2024 Aug;17(8):e70005. doi: 10.1111/cts.70005.
2
The Relevance of Integrating CYP2C19 Phenoconversion Effects into Clinical Pharmacogenetics.将CYP2C19表型转化效应整合到临床药物遗传学中的相关性。
Pharmacopsychiatry. 2024 Mar;57(2):69-77. doi: 10.1055/a-2248-6924. Epub 2024 Feb 14.
3
Therapeutic Drug Monitoring in Children and Adolescents: Findings on Fluoxetine from the TDM-VIGIL Trial.儿童和青少年的治疗药物监测：TDM-VIGIL试验中氟西汀的研究结果。
Pharmaceutics. 2023 Aug 25;15(9):2202. doi: 10.3390/pharmaceutics15092202.
4
Effect of CYP2D6 pharmacogenetic phenotype and phenoconversion on serum concentrations of antidepressants and antipsychotics: a retrospective cohort study.CYP2D6 药物遗传学表型和表型转化对抗抑郁药和抗精神病药血清浓度的影响：一项回顾性队列研究。
Int J Clin Pharm. 2023 Oct;45(5):1107-1117. doi: 10.1007/s11096-023-01588-8. Epub 2023 May 11.
5
The pharmacogenetics of and in a case series of antidepressant responses.一组抗抑郁反应病例系列中[…]和[…]的药物遗传学 （原文中“and”前后内容缺失）
Front Pharmacol. 2023 Feb 21;14:1080117. doi: 10.3389/fphar.2023.1080117. eCollection 2023.
6
CYP2D6 pharmacogenetics and phenoconversion in personalized medicine.CYP2D6 药物遗传学和个体化医学中的表型转化。
Expert Opin Drug Metab Toxicol. 2022 Nov;18(11):769-785. doi: 10.1080/17425255.2022.2160317. Epub 2023 Jan 3.
本文引用的文献
1
How to Integrate CYP2D6 Phenoconversion Into Clinical Pharmacogenetics: A Tutorial.如何将 CYP2D6 表型转化纳入临床药物遗传学：教程。
Clin Pharmacol Ther. 2021 Sep;110(3):677-687. doi: 10.1002/cpt.2354. Epub 2021 Jul 28.
2
Recommendations for Clinical CYP2D6 Genotyping Allele Selection: A Joint Consensus Recommendation of the Association for Molecular Pathology, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, and the European Society for Pharmacogenomics and Personalized Therapy.临床 CYP2D6 基因分型等位基因选择推荐：分子病理学协会、美国病理学家学院、荷兰皇家药剂师协会药物遗传学工作组以及欧洲药物基因组学和个体化治疗学会的联合共识推荐。
J Mol Diagn. 2021 Sep;23(9):1047-1064. doi: 10.1016/j.jmoldx.2021.05.013. Epub 2021 Jun 10.
3
Sequence2Script: A Web-Based Tool for Translation of Pharmacogenetic Data Into Evidence-Based Prescribing Recommendations.Sequence2Script：一种将药物遗传学数据转化为循证处方建议的基于网络的工具。
Front Pharmacol. 2021 Mar 18;12:636650. doi: 10.3389/fphar.2021.636650. eCollection 2021.
4
Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid Therapy.临床药物遗传学实施联盟指南：CYP2D6、OPRM1 和 COMT 基因型与选择性阿片类药物治疗。
Clin Pharmacol Ther. 2021 Oct;110(4):888-896. doi: 10.1002/cpt.2149. Epub 2021 Feb 9.
5
Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review.细胞色素P450代谢的表型转换：一项系统评价
J Clin Med. 2020 Sep 7;9(9):2890. doi: 10.3390/jcm9092890.
6
Standardizing CYP2D6 Genotype to Phenotype Translation: Consensus Recommendations from the Clinical Pharmacogenetics Implementation Consortium and Dutch Pharmacogenetics Working Group.标准化 CYP2D6 基因型到表型的转化：临床药物基因组学实施联盟和荷兰药物基因组学工作组的共识建议。
Clin Transl Sci. 2020 Jan;13(1):116-124. doi: 10.1111/cts.12692. Epub 2019 Oct 24.
7
Challenges and lessons learned from clinical pharmacogenetic implementation of multiple gene-drug pairs across ambulatory care settings.从多个基因-药物组合在门诊环境中的临床药物遗传学实施中获得的挑战和经验教训。
Genet Med. 2019 Oct;21(10):2264-2274. doi: 10.1038/s41436-019-0500-7. Epub 2019 Mar 30.
8
Multi-site investigation of strategies for the clinical implementation of CYP2D6 genotyping to guide drug prescribing.多中心研究 CYP2D6 基因分型指导药物处方的临床实施策略。
Genet Med. 2019 Oct;21(10):2255-2263. doi: 10.1038/s41436-019-0484-3. Epub 2019 Mar 21.
9
Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 (CYP)2D6 Genotype and Atomoxetine Therapy.临床药物遗传学实施联盟 CYP2D6 基因分型和托莫西汀治疗指南
Clin Pharmacol Ther. 2019 Jul;106(1):94-102. doi: 10.1002/cpt.1409. Epub 2019 Apr 13.
10
CYP2D6-guided opioid therapy improves pain control in CYP2D6 intermediate and poor metabolizers: a pragmatic clinical trial.CYP2D6 指导下的阿片类药物治疗可改善 CYP2D6 中代谢和弱代谢者的疼痛控制：一项实用临床试验。
Genet Med. 2019 Aug;21(8):1842-1850. doi: 10.1038/s41436-018-0431-8. Epub 2019 Jan 23.
Zotero 插件